Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Jul;37(7):1497–1503. doi: 10.1128/aac.37.7.1497

Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.

A De Sarro 1, M Zappalá 1, A Chimirri 1, S Grasso 1, G B De Sarro 1
PMCID: PMC188001  PMID: 8395790

Abstract

The behavioral and convulsant effects of cefazolin, a beta-lactam derivative, were studied after intraperitoneal administration to DBA/2 mice, a strain genetically susceptible to sound-induced seizures, and Swiss mice. DBA/2 mice were more susceptible to seizures induced by cefazolin than were Swiss mice. The proconvulsant effects of some quinolones on seizures evoked by intraperitoneal administration of cefazolin were also evaluated in DBA/2 mice. Our study also demonstrated that the order of proconvulsant activity in our epileptic model was pefloxacin > enoxacin > ofloxacin > rufloxacin > norfloxacin > cinoxacin > ciprofloxacin > nalidixic acid. The relationships between the chemical structures and proconvulsant activities of quinolone derivatives were studied. The relationship between lipophilicity and proconvulsant activity was also investigated.

Full text

PDF
1497

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akahane K., Sekiguchi M., Une T., Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother. 1989 Oct;33(10):1704–1708. doi: 10.1128/aac.33.10.1704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Antoniadis A., Müller W. E., Wollert U. Inhibition of GABA and benzodiazepine receptor binding by penicillins. Neurosci Lett. 1980 Jul;18(3):309–312. doi: 10.1016/0304-3940(80)90302-x. [DOI] [PubMed] [Google Scholar]
  3. Arcieri G., Griffith E., Gruenwaldt G., Heyd A., O'Brien B., Becker N., August R. Ciprofloxacin: an update on clinical experience. Am J Med. 1987 Apr 27;82(4A):381–386. [PubMed] [Google Scholar]
  4. Ball P. Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):187–193. doi: 10.1093/jac/18.sd.187. [DOI] [PubMed] [Google Scholar]
  5. Chapman A. G., Croucher M. J., Meldrum B. S. Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung. 1984;34(10):1261–1264. [PubMed] [Google Scholar]
  6. Chapman A. G., De Sarro G. B., Premachandra M., Meldrum B. S. Bidirectional effects of beta-carbolines in reflex epilepsy. Brain Res Bull. 1987 Sep;19(3):337–346. doi: 10.1016/0361-9230(87)90102-x. [DOI] [PubMed] [Google Scholar]
  7. De Sarro A., De Sarro G. B., Ascioti C., Nisticó G. Epileptogenic activity of some beta-lactam derivatives: structure-activity relationship. Neuropharmacology. 1989 Apr;28(4):359–365. doi: 10.1016/0028-3908(89)90030-0. [DOI] [PubMed] [Google Scholar]
  8. De Sarro A., De Sarro G. B. Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones. Neuropharmacology. 1991 Feb;30(2):169–176. doi: 10.1016/0028-3908(91)90200-u. [DOI] [PubMed] [Google Scholar]
  9. De Sarro G. B., Calò M., Bagetta G., Anfosso R., Marmo E., Nisticò G., Guarino V. Comparative epileptogenic properties of cefazolin and benzylpenicillin after intracaudate microinjection in rats. Zhongguo Yao Li Xue Bao. 1983 Dec;4(4):236–238. [PubMed] [Google Scholar]
  10. De Sarro G. B., Libri V., Ascioti C., Testa R., Nistico G. Anticonvulsant effect of denzimol in DBA/2 mice. Neuropharmacology. 1987 Sep;26(9):1425–1429. doi: 10.1016/0028-3908(87)90109-2. [DOI] [PubMed] [Google Scholar]
  11. Dimpfel W., Spüler M., Dalhoff A., Hofmann W., Schlüter G. Hippocampal activity in the presence of quinolones and fenbufen in vitro. Antimicrob Agents Chemother. 1991 Jun;35(6):1142–1146. doi: 10.1128/aac.35.6.1142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dodd P. R., Davies L. P., Watson W. E., Nielsen B., Dyer J. A., Wong L. S., Johnston G. A. Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS. Pharmacol Toxicol. 1989 May;64(5):404–411. doi: 10.1111/j.1600-0773.1989.tb00676.x. [DOI] [PubMed] [Google Scholar]
  13. Enginar N., Eroğlu L. The effect of ofloxacin and ciprofloxacin on pentylenetetrazol-induced convulsions in mice. Pharmacol Biochem Behav. 1991 Jul;39(3):587–589. doi: 10.1016/0091-3057(91)90132-l. [DOI] [PubMed] [Google Scholar]
  14. Engstrom F. L., Woodbury D. M. Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia. 1988 Jul-Aug;29(4):389–395. doi: 10.1111/j.1528-1157.1988.tb03736.x. [DOI] [PubMed] [Google Scholar]
  15. Hori S., Kurioka S., Matsuda M., Shimada J. Inhibitory effect of cephalosporins on gamma-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob Agents Chemother. 1985 Apr;27(4):650–651. doi: 10.1128/aac.27.4.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Horton R. W., Prestwich S. A., Meldrum B. S. gamma-Aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice. J Neurochem. 1982 Sep;39(3):864–870. doi: 10.1111/j.1471-4159.1982.tb07972.x. [DOI] [PubMed] [Google Scholar]
  17. Kamei C., Sunami A., Tasaka K. Epileptogenic activity of cephalosporins in rats and their structure-activity relationship. Epilepsia. 1983 Aug;24(4):431–439. doi: 10.1111/j.1528-1157.1983.tb04913.x. [DOI] [PubMed] [Google Scholar]
  18. Maesen F. P., Teengs J. P., Baur C., Davies B. I. Quinolones and raised plasma concentrations of theophylline. Lancet. 1984 Sep 1;2(8401):530–530. doi: 10.1016/s0140-6736(84)92617-5. [DOI] [PubMed] [Google Scholar]
  19. Nistico G., De Sarro G. B., Rotiroti D., Silvestri R., Marmo E. Antagonism by classical antiepileptics and sodium valproate of cefazolin in induced experimental epilepsy in rats. Res Commun Chem Pathol Pharmacol. 1980 Sep;29(3):429–444. [PubMed] [Google Scholar]
  20. Nisticò G., De Sarro G. B., Naccari F., Musolino R., Rotiroti D., Gallitto G., Di Perri R. Cefazolin: a valid model of experimental epilepsy? Monogr Neural Sci. 1980;5:14–19. doi: 10.1159/000387477. [DOI] [PubMed] [Google Scholar]
  21. Palayoor S. T., Seyfried T. N. Genetic association between Ca2+-ATPase activity and audiogenic seizures in mice. J Neurochem. 1984 Jun;42(6):1771–1774. doi: 10.1111/j.1471-4159.1984.tb12771.x. [DOI] [PubMed] [Google Scholar]
  22. Palayoor S. T., Seyfried T. N. Genetic study of cationic ATPase activities and audiogenic seizure susceptibility in recombinant inbred and congenic strains of mice. J Neurochem. 1984 Feb;42(2):529–533. doi: 10.1111/j.1471-4159.1984.tb02710.x. [DOI] [PubMed] [Google Scholar]
  23. Raoof S., Wollschlager C., Khan F. A. Ciprofloxacin increases serum levels of theophylline. Am J Med. 1987 Apr 27;82(4A):115–118. [PubMed] [Google Scholar]
  24. SUTER C., KLINGMAN W. O., LACY O. W., BOGGS D., MARKS R., COPLINGER C. B. Sound-induced seizures in animals. Neurology. 1958 Apr;8(Suppl 1):117–120. doi: 10.1212/wnl.8.suppl_1.117. [DOI] [PubMed] [Google Scholar]
  25. Schlesinger K., Boggan W., Freedman D. X. Genetics of audiogenic seizures. I. Relation to brain serotonin and norepinephrine in mice. Life Sci. 1965 Dec;4(24):2345–2351. doi: 10.1016/0024-3205(65)90289-4. [DOI] [PubMed] [Google Scholar]
  26. Schreiber R. A. Developmental changes in brain glucose, glycogen, phosphocreatine, and ATP levels in DBA/2J and C57BL/6J mice, and audiogenic seizures. J Neurochem. 1981 Sep;37(3):655–661. doi: 10.1111/j.1471-4159.1982.tb12537.x. [DOI] [PubMed] [Google Scholar]
  27. Schreiber R. A., Ungar A. L. Glucose protects DBA/2J mice from audiogenic seizures: correlation with brain glycogen levels. Psychopharmacology (Berl) 1984;84(1):128–131. doi: 10.1007/BF00432041. [DOI] [PubMed] [Google Scholar]
  28. Segev S., Rehavi M., Rubinstein E. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor. Antimicrob Agents Chemother. 1988 Nov;32(11):1624–1626. doi: 10.1128/aac.32.11.1624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Seyfried T. N., Glaser G. H. A review of mouse mutants as genetic models of epilepsy. Epilepsia. 1985 Mar-Apr;26(2):143–150. doi: 10.1111/j.1528-1157.1985.tb05398.x. [DOI] [PubMed] [Google Scholar]
  30. Ticku M. K. Differences in gamma-aminobutyric acid receptor sensitivity in inbred strains of mice. J Neurochem. 1979 Nov;33(5):1135–1138. doi: 10.1111/j.1471-4159.1979.tb05253.x. [DOI] [PubMed] [Google Scholar]
  31. Toth E., Lajtha A., Sarhan S., Seiler N. Anticonvulsant effects of some inhibitory neurotransmitter amino acids. Neurochem Res. 1983 Mar;8(3):291–302. doi: 10.1007/BF00965719. [DOI] [PubMed] [Google Scholar]
  32. Tsuji A., Sato H., Kume Y., Tamai I., Okezaki E., Nagata O., Kato H. Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother. 1988 Feb;32(2):190–194. doi: 10.1128/aac.32.2.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wijnands W. J., van Herwaarden C. L., Vree T. B. Enoxacin raises plasma theophylline concentrations. Lancet. 1984 Jul 14;2(8394):108–109. doi: 10.1016/s0140-6736(84)90283-6. [DOI] [PubMed] [Google Scholar]
  34. de Boer T., Stoof J. C., van Duyn H. Effect of penicillin on transmitter release from rat cortical tissue. Brain Res. 1980 Jun 16;192(1):296–300. doi: 10.1016/0006-8993(80)91033-1. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES